Entera Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Entera Bio and other ETFs, options, and stocks.About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2.
CEOMiranda J. Toledano
CEOMiranda J. Toledano
Employees20
Employees20
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2009
Founded2009
Employees20
Employees20
ENTX Key Statistics
Market cap103.50M
Market cap103.50M
Price-Earnings ratio-8.83
Price-Earnings ratio-8.83
Dividend yield—
Dividend yield—
Average volume72.01K
Average volume72.01K
High today$2.23
High today$2.23
Low today$2.23
Low today$2.23
Open price$2.19
Open price$2.19
Volume200.00
Volume200.00
52 Week high$3.22
52 Week high$3.22
52 Week low$1.50
52 Week low$1.50
Stock Snapshot
As of today, Entera Bio(ENTX) shares are valued at $2.23. The company's market cap stands at 103.5M, with a P/E ratio of -8.83.
On 2025-12-15, Entera Bio(ENTX) stock moved within a range of $2.23 to $2.23. With shares now at $2.23, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 200, compared to an average daily volume of 72.01K.
Over the past 52 weeks, Entera Bio(ENTX) stock has traded between a high of $3.22 and a low of $1.50.
Over the past 52 weeks, Entera Bio(ENTX) stock has traded between a high of $3.22 and a low of $1.50.
People also own
Based on the portfolios of people who own ENTX. This list is generated using Robinhood data, and it’s not a recommendation.